MediLumina
In Development Medilumina AI-Powered Market Access & Commercialization Supporting Medical Devices and Life Sciences
Why Healthcare Strategies + Medilumina Win
Consultant-led expertise scaled through AI to de-risk go-to-market process and technology adoption
Healthcare GTM fails because
- Reimbursement risk evaluation is assessed too late
- Hospital adoption economics are poorly qualified
- Market access knowledge is fragmented and non-scalable
- Consulting is high-touch, slow and difficult to productize
Result: Capital inefficiency, delayed adoption, failed commercialization
Healthcare Strategies
- 30+Years of Market Access Execution
- CMS coding, coverage & hospital adoption execution
- Rea;-world payer and provided decision insight
- Pattern recognition across hundreds of technologies
Medilumina
- AI-Powered Commercialization Platform
- Automated market access landscapes
- ROI & economic value modeling (Coming in February 2026)
- Reimbursement & payer intelligence
- Early feasibility and diligence workflows
Medilumina Advantage
- Built from 30+ years of real go-to-market experience
- Codified expert logic into repeatable workflows
- Platform + services hybrid during scale-up
- Credible with innovators, hospitals, and investors
This creates a durable moat at the intersection of policy, economics, and adoption.
- Healthcare Strategies provides the judgement.
- Medilumina provides the scale.
- Together, they unlock a category-defining market access platform